{
    "code": 200,
    "response":{
        "enrollment":{
            "categories": ["M6", "M7", "M8", "M9", "M10", "M11","M12"],
            "series":[
                {
                    "name": "New Enrollment",
                    "data": [1790,1885, 1910, 1964, 1864, 1294, 1450]
                },
                {
                    "name": "New Patient Abondonment",
                    "data": [475,535, 668, 810, 1109, 2598, 3304]
                }
            ]
        },

        "keyInsights":[
            {
                "title":"Total Enrollment", 
                "status":"Up", 
                "percent":"",
                "value":"23517",
                "items":[
                    {"title":"Enrollment for Brand A increased by 12%, Brand B increased by 9% in M12"},
                    {"title":"Total Enrollment declined from 18% to 11% between M11 to M12"}
                ]
            },
            {
                "title":"New Enrollment", 
                "status":"Up", 
                "percent":"",
                "value":"3453",
                "items":[
                    {"title":"New Enrollment through Anthem and CVS has decreased more than 20 %"},
                    {"title":"ND, NC and AZ has lowest New Enrollments (less than 200)"}
                ]
            },
            {
                "title":"Abondonment", 
                "status":"Down", 
                "percent":"21",
                "items":[
                    {"title":"Patient Abandonment from CA, GA and MA  is greater than 500 in M12"},
                    {"title":"Switch to Competition drug is the key Abandonment reason from M6 - M12", "dtlLink":true}
                ]
            }
        ]
    }
}